The table below shows Caris Life Sciences, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Operating cash flow
$32.88M
-$31.34M
Capital expenditure
$10.34M
$2.69M
Investing cash flow
-$10.34M
-$2.69M
Dividends paid
-
-
Stock buybacks
$0.00
$22.00K
Financing cash flow
$824.00K
$1.28M
CAI operating cash flow (10-K history)
Caris Life Sciences, Inc. reported operating cash flow of $83.16M for fiscal year 2025. That is up 133.9% from -$245.20M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
